Franklin Resources Portfolio holdings
Franklin Resources is the parent of the Franklin Templeton fund brands, founded in 1947 by Rupert H. Johnson Sr., a Wall Street retail broker who named it after Benjamin Franklin. Rupert Sr.'s son Charles B. Johnson became president and chief executive in 1957, and the company went public in 1971. In 1992 Franklin bought Templeton, Galbraith & Hansberger, which was then owned by mutual fund pioneer Sir John Templeton, and in 2020 it bought Legg Mason. Its fund brands include Franklin for bond funds, Templeton for international funds and Mutual Series for value funds. Its funds include Templeton Growth, opened in 1954, Mutual Shares, opened in 1949, and Mutual Discovery, opened in 1992. It launched its first ETFs in 2013 and a bitcoin and ether ETF in 2025, and in August 2026 Franklin Resources renamed itself Franklin Templeton, Inc. to match its brand.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
General Motors
GM
|
+$661M |
| 2 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$547M |
| 3 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$525M |
| 4 |
Microsoft
MSFT
|
+$515M |
| 5 |
Itaú Unibanco
ITUB
|
+$480M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHI
Baker Hughes
BHI
|
+$443M |
| 2 |
Elevance Health
ELV
|
+$297M |
| 3 |
ExxonMobil
XOM
|
+$262M |
| 4 |
LyondellBasell Industries
LYB
|
+$246M |
| 5 |
Halliburton
HAL
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.75% |
| 2 | Financials | 12.84% |
| 3 | Energy | 12.82% |
| 4 | Technology | 10.46% |
| 5 | Industrials | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Merck
MRK
$363B
| $4.29B | 1.89% |
77,668,684
+106,895
| +0.1% | +$5.83M |
2013 Q2
4 quarters
|
|
|
2
Microsoft
MSFT
$3.87T
| $3.95B | 1.74% |
94,666,510
+12,736,667
| +16% | +$515M |
2013 Q2
4 quarters
|
|
3
Medtronic
MDT
$130B
| $2.91B | 1.28% |
45,695,580
-268,109
| -0.6% | -$16.3M |
2013 Q2
4 quarters
|
|
4
Teva Pharmaceutical Industries Limited
TEVA
$50.5B
| $2.88B | 1.27% |
54,981,962
+5,708,606
| +12% | +$292M |
2013 Q2
4 quarters
|
|
5
JPMorgan Chase
JPM
$912B
| $2.82B | 1.24% |
49,001,136
+226,336
| +0.5% | +$12.7M |
2013 Q2
4 quarters
|
|
6
Chevron
CVX
$416B
| $2.77B | 1.22% |
21,249,393
+176,438
| +0.8% | +$22M |
2013 Q2
4 quarters
|
|
7
Pfizer
PFE
$168B
| $2.72B | 1.2% |
96,497,582
+11,091,388
| +13% | +$316M |
2013 Q2
4 quarters
|
|
8
Apple
AAPL
$5.17T
| $2.65B | 1.17% |
113,982,564
-7,540,040
| -6% | -$160M |
2013 Q2
4 quarters
|
|
|
RDS.A
9
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $2.51B | 1.1% |
32,592,157
-3,265,651
| -9% | -$238M |
2013 Q2
4 quarters
|
|
10
Wells Fargo
WFC
$258B
| $2.41B | 1.06% |
45,764,041
+639,429
| +1% | +$32.1M |
2013 Q2
4 quarters
|
|
11
Cisco
CSCO
$397B
| $2.15B | 0.95% |
86,598,305
-6,771,543
| -7% | -$161M |
2013 Q2
4 quarters
|
|
12
PepsiCo
PEP
$196B
| $2.05B | 0.9% |
22,985,254
+4,194,059
| +22% | +$362M |
2013 Q2
4 quarters
|
|
13
BP
BP
$117B
| $1.98B | 0.87% |
45,852,342
-7,807
| -0% | -$322K |
2013 Q2
4 quarters
|
|
14
Citigroup
C
$206B
| $1.89B | 0.83% |
40,169,375
+293,661
| +0.7% | +$14M |
2013 Q2
4 quarters
|
|
15
Johnson & Johnson
JNJ
$675B
| $1.88B | 0.83% |
17,923,851
+114,878
| +0.6% | +$11.6M |
2013 Q2
4 quarters
|
|
|
BHI
16
DELISTED
Baker Hughes
BHI
| $1.7B | 0.75% |
22,780,849
-6,363,105
| -22% | -$443M |
2013 Q2
4 quarters
|
|
17
GE Aerospace
GE
$356B
| $1.69B | 0.74% |
13,384,113
-190,187
| -1% | -$24.2M |
2013 Q2
4 quarters
|
|
18
Exelon
EXC
$47.2B
| $1.65B | 0.73% |
63,430,286
+3,059,398
| +5% | +$78M |
2013 Q2
4 quarters
|
|
19
Target
TGT
$73.9B
| $1.64B | 0.72% |
28,338,319
+7,553,088
| +36% | +$444M |
2013 Q2
4 quarters
|
|
20
Duke Energy
DUK
$100B
| $1.64B | 0.72% |
22,056,760
+68,171
| +0.3% | +$4.9M |
2013 Q2
4 quarters
|
|
|
21
General Motors
GM
$75.5B
| $1.63B | 0.72% |
45,020,975
+18,967,053
| +73% | +$661M |
2013 Q2
4 quarters
|
|
22
Southern Company
SO
$109B
| $1.62B | 0.71% |
35,613,146
+107,080
| +0.3% | +$4.73M |
2013 Q2
4 quarters
|
|
23
American International
AIG
$43B
| $1.6B | 0.71% |
29,374,772
+6,045,401
| +26% | +$320M |
2013 Q2
4 quarters
|
|
24
Eli Lilly
LLY
$1.28T
| $1.6B | 0.71% |
25,769,718
+3,240,031
| +14% | +$193M |
2013 Q2
4 quarters
|
|
|
TLM
25
DELISTED
TALISMAN ENERGY INC
TLM
| $1.55B | 0.68% |
146,867,516
+6,239,585
| +4% | +$65.1M |
2013 Q2
4 quarters
|
|
Similar funds
Franklin Resources's Q2 2014 Portfolio in Review
As of Q2 2014, Franklin Resources held 1,668 positions worth $227B, up 7.2% from $212B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Franklin Resources's Q2 2014 filing shows 140 new, 539 increased, 570 reduced and 113 closed positions. Its largest new stake was iShares 5-10 Year Investment Grade Corporate Bond ETF: 9,571,616 shares worth $527M. The largest sale was Baker Hughes, an estimated $443M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Financials and Energy.
- Franklin Resources's largest Q2 2014 buy was iShares 5-10 Year Investment Grade Corporate Bond ETF: 9,571,616 shares worth $527M.
- Franklin Resources added most to General Motors in Q2 2014, an estimated $661M increase.
- Franklin Resources's biggest Q2 2014 reduction was Baker Hughes, cutting an estimated $443M.
- Franklin Resources fully exited PEPCO HOLDINGS, INC. in Q2 2014, selling an estimated $223M.
- Franklin Resources's ten largest holdings make up 13% of its $227B portfolio in Q2 2014.
- Franklin Resources opened 140 new positions and closed 113 in Q2 2014.
- Franklin Resources's portfolio value rose 7.2% quarter-over-quarter to $227B.
Based on Franklin Resources's 13F filing for Q2 2014, filed 12 Aug 2014.